Is there a rationale for the use of antimicrobial prophylaxis in neutropenic patients?

Prophylaxis of febrile neutropenia in adults receiving chemotherapy needs to be adapted to the risk

Georgala, Aspasia
Klastersky, Jean

February 2015

A major advance in the management of febrile neutropenia (FN) has been the stratification of the pop...

Prevention of bacterial and mycotic infections in patients with hematological malignancies

Candoni A.

January 1997

Infections are a major cause of morbidity and mortality among immune-compromised patients. The autho...

Moxifloxacin prophylaxis in neutropenic patients

H. Von Baum
A. Sigge
M. Bommer
W. V. Kern
R. Marre
P. Kern
S. Reuter

January 2006

Objectives: Recent studies have shown a beneficial impact of fluoroquinolones on infection-related m...

Fluoroquinolone Prophylaxis in Neutropenic Patients Should We or Shouldn’t We?

Megan Anderson Pharm. D
Pharmacotherapy Rounds
I. Febrile Neutropenia (fn

January 2012

Objectives Review the consequences of febrile episodes in neutropenic patients Discuss the current g...

Evaluation de la prophylaxie antibiotique chez les patients neutropeniques avec hemopathie maligne. [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies]

Delarive, P.
Baumgartner, J. D.
Glauser, M. P.
Cometta, A.

December 2000

The benefits of oral prophylaxis for neutropenia have remained controversial up to now. We evaluated...

Febrile neutropenia: highlighting the role of prophylactic antibiotics and granulocyte colony-stimulating factor during standard dose chemotherapy for solid tumors.

Timmer-Bonte, J.N.H.
Tjan-Heijnen, V.C.

January 2006

Contains fulltext : 49340timmer-bonte.pdf (publisher's version ) (Closed access

Prevention of infections in neutropenic patients with pefloxacin

Meunier, Françoise

January 1990

Bacterial infections remain a major source of morbidity and mortality in neutropenic patients. There...

1874-2793/12 2012 Bentham Open Open Access Antibiotic Prophylaxis with Quinolones in Afebrile Neutropenic Patients: Is there Enough Evidence for Mortality Effect?

Gláucia Fernandes Cota
Tatiani Fereguetti
Marcos Roberto De Sousa

September 2016

Abstract: Febrile neutropenia causes significant morbidity and mortality in patients receiving antin...

Empirical and subsequent use of antibacterial agents in the febrile neutropenic patient

Pauw, B.E. de
Raemaekers, J.M.M.
Schattenberg, A.V.M.B.
Donnelly, J.P.

January 1997

Contains fulltext : 25764___.PDF (publisher's version ) (Open Access)rights: (c)RU...

Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines

Mikulska, M.
Averbuch, D.
Tissot, F.
Cordonnier, C.
Akova, M.
Calandra, T.
Ceppi, M.
Bruzzi, P.
Viscoli, C.
Bruggemann, R.J.M.
Donnelly, P.
Ward, K.
Witschi, A.T.

January 2018

Contains fulltext : 190513.pdf (publisher's version ) (Closed access)OBJECTIVES: F...

Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: A systematic review of randomised controlled trials

van de Wetering, M. D.
de Witte, M. A.
Kremer, L. C. M.
Offringa, M.
Scholten, R. J. P. M.
Caron, H. N.

January 2005

The use of oral prophylactic antibiotics in oncology patients is still a matter of debate. A systema...

Bacteremia due to oral Viridans Streptococci in Neutropenic Patients with cancer: cytostatics are a more important risk factor than antibacterial prophylaxis

Donnelly, J.P.
Dompeling, E.C.
Meis, J.F.G.M.
Pauw, B.E. de

January 1995

Contains fulltext : 21555___.PDF (publisher's version ) (Open Access

Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.

Timmer-Bonte, A.
Boo, T.M. de
Smit, H.J.
Biesma, B.
Wilschut, F.A.
Cheragwandi, S.A.
Termeer, A.
Hensing, C.A.
Akkermans, J.
Adang, E.M.M.
Bootsma, G.P.
Tjan-Heijnen, V.C.

January 2005

Contains fulltext : 47915_pub.pdf (publisher's version ) (Closed access) ...

Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies

Chong, Yong
Yakushiji, Hiroko
Ito, Yoshikiyo
Kamimura, Tomohiko

April 2011

SummaryBackgroundThe routine use of fluoroquinolone prophylaxis in patients with neutropenia and hem...

Treatment of bacteriological infections in neutropenic patients with special emphasis on ceftazidime monotherapy

Verhagen, C.A.H.H.V.M.

January 1987

Contains fulltext : mmubn000001_038049627.pdf (publisher's version ) (Open Access)...

Prophylaxis of febrile neutropenia in adults receiving chemotherapy needs to be adapted to the risk

Georgala, Aspasia
Klastersky, Jean

February 2015

A major advance in the management of febrile neutropenia (FN) has been the stratification of the pop...

Prevention of bacterial and mycotic infections in patients with hematological malignancies

Candoni A.

January 1997

Infections are a major cause of morbidity and mortality among immune-compromised patients. The autho...

Moxifloxacin prophylaxis in neutropenic patients

H. Von Baum
A. Sigge
M. Bommer
W. V. Kern
R. Marre
P. Kern
S. Reuter

January 2006

Objectives: Recent studies have shown a beneficial impact of fluoroquinolones on infection-related m...

Fluoroquinolone Prophylaxis in Neutropenic Patients Should We or Shouldn’t We?

Megan Anderson Pharm. D
Pharmacotherapy Rounds
I. Febrile Neutropenia (fn

January 2012

Objectives Review the consequences of febrile episodes in neutropenic patients Discuss the current g...

Evaluation de la prophylaxie antibiotique chez les patients neutropeniques avec hemopathie maligne. [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies]

Delarive, P.
Baumgartner, J. D.
Glauser, M. P.
Cometta, A.

December 2000

The benefits of oral prophylaxis for neutropenia have remained controversial up to now. We evaluated...

Febrile neutropenia: highlighting the role of prophylactic antibiotics and granulocyte colony-stimulating factor during standard dose chemotherapy for solid tumors.

Timmer-Bonte, J.N.H.
Tjan-Heijnen, V.C.

January 2006

Contains fulltext : 49340timmer-bonte.pdf (publisher's version ) (Closed access

Prevention of infections in neutropenic patients with pefloxacin

Meunier, Françoise

January 1990

Bacterial infections remain a major source of morbidity and mortality in neutropenic patients. There...

1874-2793/12 2012 Bentham Open Open Access Antibiotic Prophylaxis with Quinolones in Afebrile Neutropenic Patients: Is there Enough Evidence for Mortality Effect?

Gláucia Fernandes Cota
Tatiani Fereguetti
Marcos Roberto De Sousa

September 2016

Abstract: Febrile neutropenia causes significant morbidity and mortality in patients receiving antin...

Empirical and subsequent use of antibacterial agents in the febrile neutropenic patient

Pauw, B.E. de
Raemaekers, J.M.M.
Schattenberg, A.V.M.B.
Donnelly, J.P.

January 1997

Contains fulltext : 25764___.PDF (publisher's version ) (Open Access)rights: (c)RU...

Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines

Mikulska, M.
Averbuch, D.
Tissot, F.
Cordonnier, C.
Akova, M.
Calandra, T.
Ceppi, M.
Bruzzi, P.
Viscoli, C.
Bruggemann, R.J.M.
Donnelly, P.
Ward, K.
Witschi, A.T.

January 2018

Contains fulltext : 190513.pdf (publisher's version ) (Closed access)OBJECTIVES: F...

Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: A systematic review of randomised controlled trials

van de Wetering, M. D.
de Witte, M. A.
Kremer, L. C. M.
Offringa, M.
Scholten, R. J. P. M.
Caron, H. N.

January 2005

The use of oral prophylactic antibiotics in oncology patients is still a matter of debate. A systema...

Bacteremia due to oral Viridans Streptococci in Neutropenic Patients with cancer: cytostatics are a more important risk factor than antibacterial prophylaxis

Donnelly, J.P.
Dompeling, E.C.
Meis, J.F.G.M.
Pauw, B.E. de

January 1995

Contains fulltext : 21555___.PDF (publisher's version ) (Open Access

Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.

Timmer-Bonte, A.
Boo, T.M. de
Smit, H.J.
Biesma, B.
Wilschut, F.A.
Cheragwandi, S.A.
Termeer, A.
Hensing, C.A.
Akkermans, J.
Adang, E.M.M.
Bootsma, G.P.
Tjan-Heijnen, V.C.

January 2005

Contains fulltext : 47915_pub.pdf (publisher's version ) (Closed access) ...

Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies

Chong, Yong
Yakushiji, Hiroko
Ito, Yoshikiyo
Kamimura, Tomohiko

April 2011

SummaryBackgroundThe routine use of fluoroquinolone prophylaxis in patients with neutropenia and hem...

Treatment of bacteriological infections in neutropenic patients with special emphasis on ceftazidime monotherapy

Verhagen, C.A.H.H.V.M.

January 1987

Contains fulltext : mmubn000001_038049627.pdf (publisher's version ) (Open Access)...

Prophylaxis of febrile neutropenia in adults receiving chemotherapy needs to be adapted to the risk

Georgala, Aspasia
Klastersky, Jean

February 2015

A major advance in the management of febrile neutropenia (FN) has been the stratification of the pop...

Prevention of bacterial and mycotic infections in patients with hematological malignancies

Candoni A.

January 1997

Infections are a major cause of morbidity and mortality among immune-compromised patients. The autho...

Moxifloxacin prophylaxis in neutropenic patients

H. Von Baum
A. Sigge
M. Bommer
W. V. Kern
R. Marre
P. Kern
S. Reuter

January 2006

Objectives: Recent studies have shown a beneficial impact of fluoroquinolones on infection-related m...

Is there a rationale for the use of antimicrobial prophylaxis in neutropenic patients?

Abstract

Extracted data

Is there a rationale for the use of antimicrobial prophylaxis in neutropenic patients?

Abstract

Extracted data

Related items

Related items